We are live on ! Find out more
DRZID

DePrince Race & Zollo Inc (DRZ) Portfolio holdings

AUM $5.29B
1-Year Est. Return 20.14%
This Fund
S&P 500
This Quarter Est. Return
-6.13%
1 Year Est. Return
+20.14%
3 Year Est. Return
+36.34%
5 Year Est. Return
+39.16%
10 Year Est. Return
+157.08%
AUM
$7.4B
AUM Growth
-$1.12B
Cap. Flow
-$592M
Cap. Flow %
-8%
Top 10 Hldgs %
13.14%
Holding
336
New
39
Increased
75
Reduced
165
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$88.5M
2
PX
Praxair Inc
PX
+$71.2M
3
KO icon
Coca-Cola
KO
+$67.1M
4
WBA
Walgreens Boots Alliance
WBA
+$51.4M
5
FLO icon
Flowers Foods
FLO
+$49.3M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$100M
2
URS
URS CORP
URS
+$86.4M
3
NTRS icon
Northern Trust
NTRS
+$82M
4
BNY
Bank of New York Mellon
BNY
+$78.1M
5
KSS icon
Kohl's
KSS
+$62.7M

Sector Composition

Rank Sector Weight
1 Financials 23.45%
2 Consumer Discretionary 14.54%
3 Industrials 14.15%
4 Energy 10.59%
5 Technology 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BID
101
DELISTED
Sotheby's
BID
$33.8M 0.46%
+946,768
New +$37.3M
NBHC icon
102
National Bank Holdings
NBHC
$1.92B
$32.6M 0.44%
1,703,760
-97,438
-5% -$1.93M
NWBI icon
103
Northwest Bancshares
NWBI
$2.3B
$32.4M 0.44%
2,680,758
+715,585
+36% +$9.04M
GEF icon
104
Greif
GEF
$5B
$32.1M 0.43%
732,776
+82,571
+13% +$4.12M
ADTN icon
105
Adtran
ADTN
$665M
$31.3M 0.42%
1,526,452
+310,578
+26% +$6.95M
BGG
106
DELISTED
Briggs & Stratton Corp.
BGG
$31.3M 0.42%
1,738,628
+262,110
+18% +$5.13M
RITM icon
107
Rithm Capital
RITM
$5.71B
$31.2M 0.42%
2,679,271
-91,700
-3% -$1.14M
TCF
108
DELISTED
TCF Financial Corporation Common Stock
TCF
$31M 0.42%
1,151,713
+10,389
+0.9% +$290K
ONB icon
109
Old National Bancorp
ONB
$10.4B
$30.3M 0.41%
2,337,533
+194,550
+9% +$2.63M
CFFN icon
110
Capitol Federal Financial
CFFN
$1.1B
$30.2M 0.41%
2,555,537
-85,810
-3% -$1.03M
KRO icon
111
KRONOS Worldwide
KRO
$905M
$30M 0.4%
2,174,888
-69,543
-3% -$1.07M
COHU icon
112
Cohu
COHU
$2.66B
$29.9M 0.4%
2,495,250
-360,446
-13% -$4.23M
FWRD icon
113
Forward Air
FWRD
$658M
$29.5M 0.4%
657,798
-20,080
-3% -$939K
IBKC
114
DELISTED
IBERIABANK Corp
IBKC
$29.4M 0.4%
470,584
-15,980
-3% -$1.05M
UVV icon
115
Universal Corp
UVV
$1.13B
$28.6M 0.39%
644,565
-10,700
-2% -$552K
SSI
116
DELISTED
Stage Stores Inc
SSI
$28.4M 0.38%
1,659,140
+149,544
+10% +$2.68M
SSD icon
117
Simpson Manufacturing
SSD
$7.99B
$27.3M 0.37%
935,087
+211
+0% +$6.83K
AF
118
DELISTED
Astoria Financial Corporation
AF
$27.2M 0.37%
2,195,296
-209,985
-9% -$2.74M
PBCT
119
DELISTED
People's United Financial Inc
PBCT
$27M 0.36%
1,866,567
-110,680
-6% -$1.64M
COLB icon
120
Columbia Banking Systems
COLB
$9.12B
$27M 0.36%
1,088,257
+220,895
+25% +$5.7M
DAC icon
121
Danaos Corp
DAC
$2.55B
$26.1M 0.35%
363,341
+8,337
+2% +$670K
GSL icon
122
Global Ship Lease
GSL
$1.49B
$24.7M 0.33%
769,027
-54,607
-7% -$1.71M
RDUS
123
DELISTED
Radius Recycling
RDUS
$24M 0.32%
+997,959
New +$26.5M
HAYN
124
DELISTED
Haynes International, Inc.
HAYN
$24M 0.32%
521,025
+9,195
+2% +$471K
PWE
125
DELISTED
Penn West Energy Petroleum Ltd
PWE
$23.8M 0.32%
3,524,984
+43,867
+1% +$347K

Similar funds

DePrince Race & Zollo Inc (DRZ)'s Q3 2014 Portfolio in Review

As of Q3 2014, DePrince Race & Zollo Inc (DRZ) held 336 positions worth $7.4B, down 13% from $8.52B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

DePrince Race & Zollo Inc (DRZ) withdrew a net $592M in Q3 2014, closing 54 positions and reducing 165 holdings. Its most notable exit was Amgen, an estimated $100M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, DePrince Race & Zollo Inc (DRZ) opened a new position in Pfizer worth $88.5M.

  • DePrince Race & Zollo Inc (DRZ)'s largest Q3 2014 buy was Pfizer: 3,153,779 shares worth $88.5M.
  • DePrince Race & Zollo Inc (DRZ) added most to Emerson Electric in Q3 2014, an estimated $34.5M increase.
  • DePrince Race & Zollo Inc (DRZ)'s biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $44.4M.
  • DePrince Race & Zollo Inc (DRZ) fully exited Amgen in Q3 2014, selling an estimated $100M.
  • DePrince Race & Zollo Inc (DRZ)'s ten largest holdings make up 13% of its $7.4B portfolio in Q3 2014.
  • DePrince Race & Zollo Inc (DRZ) opened 39 new positions and closed 54 in Q3 2014.
  • DePrince Race & Zollo Inc (DRZ)'s portfolio value fell 13% quarter-over-quarter to $7.4B.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q3 2014, filed 30 Oct 2014.